Your browser doesn't support javascript.
loading
Venetoclax in upfront induction therapy for primary plasma cell leukemia with t(11;14) or BCL2 expression.
Roy, Tina; An, Joseph B; Doucette, Kimberly; Chappell, Aimee M; Vesole, David H.
Afiliação
  • Roy T; Division of Hematology and Oncology Georgetown University School of Medicine Washington, DC, USA.
  • An JB; Division of Hematology and Oncology Georgetown University School of Medicine Washington, DC, USA.
  • Doucette K; Division of Hematology and Oncology Georgetown University School of Medicine Washington, DC, USA.
  • Chappell AM; Division of Hematology and Oncology Georgetown University School of Medicine Washington, DC, USA.
  • Vesole DH; Division of Hematology and Oncology Georgetown University School of Medicine Washington, DC, USA.
Leuk Lymphoma ; 63(3): 759-761, 2022 03.
Article em En | MEDLINE | ID: mdl-35076333
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Plasmocitária / Antineoplásicos Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Leuk Lymphoma Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Plasmocitária / Antineoplásicos Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Leuk Lymphoma Ano de publicação: 2022 Tipo de documento: Article